Status:
COMPLETED
Risk of Infection of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), COVID-19, in a Massive Musical Show With Transmission Prevention Measures
Lead Sponsor:
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
Collaborating Sponsors:
Dr. Bonaventura Clotet Sala
Dr. Josep Mª LLibre Codina
Conditions:
COVID-19 (SARS-CoV-2)
Eligibility:
All Genders
18-59 years
Phase:
NA
Brief Summary
The coronavirus disease 2019 (COVID-19) outbreak, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in Wuhan in December 2019 and has spread globally, representing a ...
Detailed Description
The coronavirus disease 2019 (COVID-19) outbreak, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in Wuhan in December 2019 and has spread globally, representing a ...
Eligibility Criteria
Inclusion
- Adults (age 18-59 years) with interest to attend the scheduled musical event who agree to participate in the study after signing the informed consent, including explicit acceptance of the measures implemented to reduce the risk of transmission of SARS-CoV-2.
- Negative antigen test performed up to 24 h before the event, in nasopharyngeal swab.
Exclusion
- Hypertension
- Diabetes Mellitus.
- Ischemic heart disease.
- Any type of Cancer in active treatment.
- Chronic lung diseases such as chronic obstructive pulmonary disease (COPD) and asthma.
- Have a positive test for detection of SARS-CoV-2 by the rapid antigen test
- Who have a body temperature higher than 37.0º on the same day of the event
- Who have a confirmed diagnosis for SARS-CoV-2 in the two weeks prior to the event
- Report any symptoms suggestive of a SARS-CoV-2 infection in the 10 days prior to the study
- Who have been in contact with a person with a confirmed diagnosis of SARS-CoV-2 infection within two weeks prior to the event.
- Living with a person over 70 years of age (inclusive).
Key Trial Info
Start Date :
November 30 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 8 2021
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04668625
Start Date
November 30 2020
End Date
January 8 2021
Last Update
February 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Germans Trias i Pujol Hospital
Badalona, Barcelona, Spain, 08916